inPractice® and American Association for the Study of Liver Diseases Announce Collaboration in Hepatology Education and Reference

Leading liver disease society endorses point-of-care decision support tool

inPractice® Resources, LLC, today announced that the American Association for the Study of Liver Diseases (AASLD) has endorsed inPractice Hepatology, an education and reference tool for its members, hepatologists, and other clinicians who treat patients with liver disease. AASLD will also support additional content development, and inPractice will also proudly showcase the AASLD logomark on its hepatology program. inPractice outreach efforts will be supported and officially endorsed by AASLD.

inPractice is designed to meet the reference and educational needs of specialists, with deep, specialty-specific information and recommendations for patient care. inPractice is currently available in specialties including hepatology, HIV, oncology, oncology nursing, and rheumatology, with plans to expand into additional specialties.

Clinicians can browse specific original expert-authored content developed by the inPractice world-renowned authors, led by inPractice Hepatology Editors-in-Chief Nezam H. Afdhal, MD, FRCPI, and Stefan Zeuzem, MD, or quickly search for information from multiple clinical databases simultaneously, including the latest drug information, PubMed abstracts, practice guidelines, clinical trials, and CME-certified activities. The system, the first of its kind for specialists, offers a seamless blend of reference and education, with Point of Care CME credits earned for topics searched.

AASLD is the leading organization of scientists and healthcare professionals committed to treating and curing liver disease. Under the agreement, AASLD will contribute clinical content for adaptation into inPractice Hepatology to broaden the range of topics from its currently available viral hepatitis content to additional areas of liver disease. AASLD will also partner with inPractice to publicize the value of inPractice and encourage its use by AASLD members and other liver disease specialists.

Adrian M. Di Bisceglie, MD, FACP, President of the AASLD Governing Board said, “Our two organizations share a common goal: enhancing the quality of care for patients with liver disease by ensuring their clinicians have access to state-of-the-art information, educational content, and practice guidelines. AASLD believes that the inPractice resource provides an excellent blend of education and reference, and we are delighted to support its adoption among our members.”

“We are proud to partner with AASLD,” added Edward King, MA, Chief Innovation Officer of inPractice. “The inPractice technology platform allows clinicians to quickly and easily access clinical information and recommendations at the point of care. Our partnership with AASLD will help us to expand both the content and the utilization of inPractice Hepatology, making it an even more valuable resource.”

About inPractice
inPractice, a subsidiary of Clinical Care Options, is a point-of-care clinical reference tool designed for specialists. Available in specialties including hepatology, HIV, oncology, oncology nursing and rheumatology, inPractice offers focused specialty-based content written specifically for patient care and a seamless blend of reference and education, with earned CME for topics searched. inPractice Africa is the latest resource to be produced by inPractice, authored by expert African clinicians for healthcare professionals working in resource-constrained settings. For more information, visit

About Clinical Care Options
Clinical Care Options is the leader in the development of innovative educational technology platforms that integrate all levels of medical education and information with personalization and moderated social media. CCO has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals for more than a decade. For more information, visit

About the AASLD
AASLD is a medical subspecialty society representing clinicians and researchers in liver disease. The work of our members has laid the foundation for the development of drugs used to treat patients with viral hepatitis. Access to care and support of liver disease research are at the center of AASLD’s advocacy efforts.

AASLD is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. AASLD was founded in 1950 by a small group of leading liver specialists and has grown to an international society responsible for all aspects of hepatology.

Additional information about AASLD may be found online at

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.